Alphamab Oncology (9966.HK) HKSE

10.75

+0.42(+4.07%)

Updated at September 08 03:46PM

Currency In HKD

Valuation

Market Cap3.22B
Enterprise Value2.29B
P/E Ratio58.28
PEG Ratio0.34
Price/Sales Ratio14.92
Price/Book Ratio5.29
Enterprise/Revenue13.47
Enterprise/EBITDA55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.26
Operating Margin0.16

Management Effectiveness

Return On Assets0.07
Return On Equity0.1

Income Statement

Revenue640.08M
Revenue/Share0.65
Gross Profit579.77M
EBITDA156.79M
Net Income166.34M
Diluted EPS0.17

Balance Sheet

Total Cash1.57B
Total Cash/Share1.59
Total Debt185.96M
Total Debt/Equity0.1
Current Ratio6.74
Book Value Per Share1.86

Price History

52-Week Change369.43
52-Week High11.3
52-Week Low2.16
Moving Average 50 Days8.67
Moving Average 200 Days6.32

Statistics

Average Volume4.25M
Shares Outstanding971.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A